Relay Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview

Relay Therapeutics

05/08/2025 21:59

Relay Therapeutics Inc RLAY.OQ RLAY.O is expected to  show a rise in quarterly revenue when it reports  results on August 7 for the period ending June 30 2025

The Cambridge Massachusetts-based  company is expected to report revenue of $60 thousand, according to the mean estimate from 10 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for Relay Therapeutics Inc is for a loss of 49 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for Relay Therapeutics Inc is $14.00, about 73.9% above its last closing price of $3.65

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.49
-0.49
-0.46
Beat
5.7
Dec. 31 2025
-0.56
-0.56
-0.45
Beat
19.9
Sep. 30 2024
-0.76
-0.77
-0.63
Beat
17.9‚Äč
Jun. 30 2024
-0.73
-0.73
-0.69
Beat
5.8
‚Äč‚ÄčMar. 31 2024
-0.69
-0.70
-0.62
Beat
12
Dec. 31 2023
-0.69
-0.73
-0.67
Beat
8‚Äč
Sep. 30 2023
-0.82
-0.83
-0.54
Beat
35
Jun. 30 2023
-0.84
-0.82
-0.81
Beat
0.7

This summary was machine generated August 5 at 20:59 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)